Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > Druggability Technologies Appoints Louis Scotti as Chief Business Development Officer

Abstract:
Druggability Technologies Holdings Limited (DRGT), a privately held biotechnology platform company, today announced the appointment of Louis Scotti to the newly created position of Chief Business Development Officer. Mr. Scotti will be responsible for all business development activities and managing the company's numerous existing collaborations for its NanoActive™ technology platform, which significantly improves the solubility, permeability and pharmacokinetics of diverse chemical and biological compounds.

Druggability Technologies Appoints Louis Scotti as Chief Business Development Officer

Dublin, Ireland | Posted on August 3rd, 2012

"We are pleased that Mr. Scotti has joined our senior management team at DRGT," said Gabor Heltovics, CEO of DRGT. "With his long track record of concluding major drug development collaborations with pharmaceutical and biotechnology companies worldwide, Mr. Scotti will be an integral part of our efforts to expand the successful application of our proprietary technologies."

Mr. Scotti most recently served in senior commercial roles during a 12-year career at Arena Pharmaceuticals, Inc., a NASDAQ listed company that recently received FDA approval of Belviq® (lorcaserin HCl), the first prescription weight-loss treatment approved by FDA in 13 years. At Arena, Mr. Scotti held several positions, including Vice President Business Development, Vice President Marketing & Business Development and Vice President Commercial Planning. He was directly responsible for corporate alliances with major pharmaceutical companies such as Merck, J&J and Eli Lilly. Previously, Mr. Scotti was CEO of ProtoMed, Inc. and earlier headed licensing activities as executive director for Ligand Pharmaceuticals, Inc. Mr. Scotti holds a B.S.E. in biomedical engineering from the University of Pennsylvania.

####

About Druggability Technologies Holdings Limited (DRGT)
Headquartered in Dublin, Ireland, DRGT, through its subsidiaries, is developing and commercializing its proprietary NanoActive™ high throughput technology platform. This platform delivers significant improvements in compound solubility, permeability and pharmacokinetics that can be applied across a diverse universe of chemical and biological compounds.

The Company's experience in improving the bioavailability and kinetic profile of drugs is born of a heritage of three decades of scientific and industrial knowledge gained through successful commercial ventures in bio- and chemo-informatics, combinatorial chemistry, chemical genomics, flow chemistry, colloidal chemistry, and nanotechnology.

For more information, please click here

Contacts:
Druggability Technologies Holdings Ltd.
Gabor Heltovics
Chief Executive Officer
+36-1-8808-468
+36-1-8808-501 (FAX)

Copyright © Marketwire

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Electric-car battery materials could harm key soil bacteria February 11th, 2016

Creating a color printer that uses a colorless, non-toxic ink inspired by nature February 11th, 2016

SLAC X-ray laser turns crystal imperfections into better images of important biomolecules: New method could remove major obstacles to studying structures of complex biological machines February 11th, 2016

Nanoparticle reduces targeted cancer drug's toxicity February 11th, 2016

Nanomedicine

Canadian Scientists Develop Innovative Protein Test for Zika February 11th, 2016

SLAC X-ray laser turns crystal imperfections into better images of important biomolecules: New method could remove major obstacles to studying structures of complex biological machines February 11th, 2016

Nanoparticle reduces targeted cancer drug's toxicity February 11th, 2016

Nanoparticle therapy that uses LDL and fish oil kills liver cancer cells February 9th, 2016

Announcements

Research reveals carbon films can give microchips energy storage capability: International team from Drexel University and Paul Sabatier University reveals versatility of carbon films February 11th, 2016

Creating a color printer that uses a colorless, non-toxic ink inspired by nature February 11th, 2016

SLAC X-ray laser turns crystal imperfections into better images of important biomolecules: New method could remove major obstacles to studying structures of complex biological machines February 11th, 2016

Nanoparticle reduces targeted cancer drug's toxicity February 11th, 2016

Appointments/Promotions/New hires/Resignations/Deaths

NSS Pays Tribute to Late NSS Governor Dr. Marvin Minsky, A Pioneer in Artificial Intelligence February 11th, 2016

Tesla NanoCoatings Gains Talents of Joe Davis as Vice President-Sales Engineer January 27th, 2016

Semblant Appoints Donald Cunningham as Chief Commercial Officer January 2nd, 2016

Beneq introduces new growth strategy and company structure - Jukka Nieminen appointed President December 15th, 2015

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







Car Brands
Buy website traffic